Abivax - ADR

Abivax - ADR

ABVX

Get informed when a big investor buys or sells

+ Follow
Market Cap$6.33B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Abivax - ADRAbivax - ADR-17.6--90%-0.1
$115.50

Target Price by Analysts

19.6% upsideAbivax Target Price DetailsTarget Price
$8.03

Current Fair Value

91.7% downside

Overvalued by 91.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.33 Billion
Enterprise Value$5.85 Billion
Dividend Yield$- (-)
Earnings per Share$-4.65
Beta-0.2
Outstanding Shares69,527,315

Return

Return on Equity-90.32%ROE
Return on Assets-70.36%
Return on Invested Capital-62.80%

Valuation & Multiples

P/E Ratio-17.59P/E Ratio
PEG-4.76PEG
Price to Sales-Price to Sales
Price to Book Ratio16.09Price to Book Ratio
Enterprise Value to Revenue1083.43
Enterprise Value to EBIT-17.87
Enterprise Value to Net Income-15
Total Debt to Enterprise0.01
Debt to Equity0.07Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
June 1, 2026
EPS Estimate
$-0.92
Average shareholder expectation
Revenue Estimate
$602,961
Average shareholder expectation

Next Earnings Call

Expected Date
September 14, 2026
EPS Estimate
$-0.88
Average shareholder expectation
Revenue Estimate
$943,151
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5978 5.27%
Total Calls1,849,983 22.05%
Total Puts1,105,853 28.37%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %71.97% 16.83%
Total Invested$5.53B 27.28%
Investors Holding285 11.00%

ESG Score

No data

About Abivax